Articles dans des revues avec comité de lecture (78)
  1. 75. Roufosse, F., Schandené, L., Sibille, C., Kennes, B., Efira, A., Cogan, E., & Goldman, M. (1999). T-cell receptor -independent activation of clonal Th2 cells associated with chronic hypereosinophilia. Blood, 94, 994-1002.
  2. 76. Matte, J., Roufosse, F., Rocmans, P. A., Schoutens, A., Jacobovitz, D., & Mockel, J. (1998). Ectopic Cushing's syndrome and pulmonary carcinoid tumour identified by [111In-DTPA-D-Phe1]octreotide. Postgraduate medical journal, 74(868), 108-110.
  3. 77. Roufosse, F., Bartholomé, E., Schandené, L., Goldman, M., & Cogan, E. (1998). The idiopathic hypereosinophilic syndrome: clinical presentation, pathogenesis and therapeutic strategies. Drugs of Today, 34(4), 361-373.
  4. 78. Bartholomé, E., & Roufosse, F. (1997). Advances in immunotherapy immunoregulatory properties of type-I interferons: Relevance to multiple sclerosis and the hypereosinophilic syndrome. Acta clinica Belgica (Ed. multilingue), 52(6), 350-359.
    5.   Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (7)
  5. 1. Requena, G., Roufosse, F., Baylis, L. L., & Steinfeld, J. (2021). Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab. Respirology Case Reports, 9(2), e00707. doi:10.1002/rcr2.707
  6. 2. Roufosse, F. (2014). Peripheral T-cell lymphoma developing after diagnosis of lymphocytic variant hypereosinophilic syndrome: Misdiagnosed lymphoma or natural disease progression? Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 118(4), 506-510. doi:10.1016/j.oooo.2014.04.018
  7. 3. Roufosse, F., Klion, A. D., & Weller, P. F. (2009). Treatment of the hypereosinophilic syndromes.
  8. 4. Roufosse, F., Goldman, M., & Cogan, E. (2006). Hypereosinophilic syndromes: a novel therapeutic indication for tyrosine kinase inhibitors and IL-5 antagonists. Drug Discovery Today: Therapeutic Strategies, 3(1) , 55-61.
  9. 5. Roufosse, F., Goldman, M., & Cogan, E. (2003). Hypereosinophilic syndrome. The New England journal of medicine, 348(26), 2687.
  10. 6. Cogan, E., Decaux, G., Neve, P., & Roufosse, F. (2002). The general internal medicine department. Revue Medicale de Bruxelles, 23 , 97-100.
  11. 7. Roufosse, F., Schandené, L., & Cogan, E. (2000). Idiopathic eosinophilia. The New England journal of medicine, 342(9), 660.
    12.   Thèses et mémoires (1)
  12. 1. Roufosse, F. (2001). Clonal expansion of helper type 2 lymphocytes as a cause of the hypereosiophilic syndrome: clinical and immunological aspects (Thèse doctorale non-publiée). Université libre de Bruxelles, Faculté de Médecine – Médecine, Bruxelles.
    13. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>